摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

螺[4.5]癸烷-2,4-二酮 | 88869-10-7

中文名称
螺[4.5]癸烷-2,4-二酮
中文别名
——
英文名称
Spiro<4.5>decane-1,3-dione
英文别名
spiro[4.5]decane-1,3-dione;Spiro[4.5]decan-1,3-dion;Cyclohexan-cyclopentandion-(2'.4')-spiran-(1.1');1.1-Pentamethylen-cyclopentandion-(2.4);Cyclohexan-spiro-cyclopentandion-(2.4);spiro[4.5]decane-2,4-dione
螺[4.5]癸烷-2,4-二酮化学式
CAS
88869-10-7
化学式
C10H14O2
mdl
——
分子量
166.22
InChiKey
DNJNZJPMEZJNKB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    34.1
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:39657d0841ff7972a7d8804983500398
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Novel diazepan derivatives
    申请人:Aebi Johannes
    公开号:US20070249589A1
    公开(公告)日:2007-10-25
    The invention is concerned with novel diazepan derivatives of formula (I) wherein A, X, R 3 , R 4 , R 5 , R 6 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
    这项发明涉及式(I)的新型二氮杂环己烷生物,其中A、X、R3、R4、R5、R6、R8、R9、R10、R11、R12、R13、m和n的定义如描述和索赔中所述,以及其生理上可接受的盐。这些化合物是CCR-2受体、CCR-5受体和/或CCR-3受体的拮抗剂,可用作药物。
  • [EN] 1 - AZA - SPIRO [4.5] DEC- 3 - ENE AND 1, 8 - DIAZA - SPIRO [4.5 ] DEC- 3 - ENE DERIVATIVES AS PESTICIDES<br/>[FR] DÉRIVÉS DE 1-AZA-SPIRO[4.5]DÉC-3-ÈNE ET DE 1,8-DIAZA-SPIRO[4.5]DÉC-3-ÈNE EN TANT QUE PESTICIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2013150015A1
    公开(公告)日:2013-10-10
    A compound of the formula (I), wherein the substituents are as defined in claim 1, are useful as a pesticides.
    式(I)的化合物,其中取代基如权利要求1所定义的那样,可用作杀虫剂
  • 4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES
    申请人:Christ Andreas D.
    公开号:US20080293756A1
    公开(公告)日:2008-11-27
    This invention relates to 4,4-disubstituted piperidine derivatives of the formula wherein A and R 1 to R 5 are as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
    这项发明涉及公式 的4,4-二取代哌啶生物,其中A和R1至R5如规范中所定义,并其药学上可接受的盐。该发明还涉及含有这种化合物的药物组合物,以及用于制备它们的方法和它们用于治疗和/或预防与调节SST受体亚型5相关的疾病的用途。
  • Novel heteroaryl substituted piperidine derivatives which are L-CPT1 inhibitors
    申请人:Ackermann Jean
    公开号:US20070129544A1
    公开(公告)日:2007-06-07
    The invention is concerned with novel substituted piperidine derivatives of formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and X are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.
    这项发明涉及式(I)的新型替代哌啶生物,其中R1、R2、R3、R4、R5、R6、R7和X的定义如说明书和权利要求中所述,以及其生理上可接受的盐和酯。这些化合物抑制L-CPT1,可用作药物。
  • LTA4H Modulators
    申请人:Axe U. Frank
    公开号:US20050043379A1
    公开(公告)日:2005-02-24
    Leukotriene A4 hydrolase (LTA4H) inhibitors, compositions containing them, and methods of use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated with inflammation.
    Leukotriene A4解酶(LTA4H)抑制剂,含有它们的组合物,以及用于抑制LTA4H酶活性和治疗、预防或抑制炎症和/或与炎症相关的病症的使用方法。
查看更多